<SEC-DOCUMENT>0001607062-17-000372-index.html : 20171106 <SEC-HEADER>0001607062-17-000372.hdr.sgml : 20171106 <ACCEPTANCE-DATETIME>20171106164444 ACCESSION NUMBER: 0001607062-17-000372 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171106 DATE AS OF CHANGE: 20171106 EFFECTIVENESS DATE: 20171106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0320 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 171179958 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>gnbt110617def14a.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: gnbt110617def14a.htm
</DOCUMENT> </SEC-DOCUMENT>